SDGR - Schrödinger Inc. Debt to Book Capitalization Ratio

Brandmark of Schrödinger Inc. (SDGR)

Schrodinger, Inc. (SDGR) possesses significant market influence, as its quantum physics-based software radically reduces drug development timelines. The stock's price history confirms the significance of these technologies, with the current metric standing at 0.31. The company has created an indispensable digital environment for biochemistry by integrating cloud computing with simulation. High computational load is driving a systematic expansion of infrastructure to ensure seamless operations for clients.

Schrodinger Corp (SDGR) - Debts to Book Value from 07/04/2022 to 10/28/2026
Brand item of Schrodinger Inc

To identify fundamental support for Schrodinger, Inc. (SDGR), it is essential to evaluate the balance between debt obligations and equity, which is critical when financing the R&D pipeline and the development of the AI platform. By analyzing the debt-to-market cap chart, an investor determines the degree of financial leverage and the risk of over-indebtedness, where a declining ratio confirms the asset's high autonomy and reliability during the development of new drugs.

Who Schrodinger, Inc. competes with

Debt to Book Value Veeva Systems Inc.|doximity.com - Debt to Net Assets Ratio|HQY: Debt to Book Capitalization Ratio|WAY - Debt to Book Value|Debts to Book Capitalization CRVL|Privia Medical Group (PRVA) - Debts to Book Value|Debts to Book Capitalization Huron Consulting Group (HURN)|Debt to Book Value Ratio CERT|OMCL (Omnicell) - Debt to Book Capitalization Ratio|Debts to Net Assets GoodRx Inc (GDRX)|Phreesia Corp - Debts to Book Capitalization|Debt to Book Value Omada OMDA|Debts to Book Capitalization Evolent Health, Inc. (EVH)|HSTM: Debt to Net Assets Ratio|Debt to Book Capitalization Ratio Definitive Healthcare Corp. DH|CCSI (Consensus Cloud Solutions Inc) - Debt to Net Assets Ratio|Debt to Book Capitalization Ratio AGL (agilon health Inc)|Debts to Book Value Absci Bio|Debts to Book Capitalization So-Young International SY|Debt to Book Value Ratio National Research Corporation (NRC)|Debts to Book Capitalization SPOK|OptimizeRx Corp - Debts to Net Assets|CPSI (TBRG) - Debt to Book Capitalization Ratio|SLP - Debt to Book Value Ratio|Debts to Book Capitalization SOPH (sophiagenetics.com)|healthcatalyst.com (HCAT) - Debt to Net Assets|Debts to Book Capitalization CCLD (CareCloud Inc.)|Debts to Book Value RSSS|DLH Holdings Corp. (DLHC) - Debt to Book Capitalization Ratio|Debt to Net Assets Ratio onemednet.com ONMD|Debt to Book Value Scienture Holdings Inc|Debt to Net Assets Ratio healthcaretriangle.com HCTI|Debts to Book Capitalization ISPC (iSpecimen Corp)|BFRG: Debts to Net Assets|Debt to Book Capitalization Ratio SCWorx Corporation|MSP Recovery Corp (MSPR) - Debt to Book Value Ratio|Debts to Book Capitalization ICCT|Debt to Book Value trxadehealth.com (MEDS)|ORGS (Orgenesis) - Debt to Book Value|Debts to Net Assets RCM (r1rcm.com)|Debt to Book Capitalization Ratio SHCR|Debts to Net Assets Streamline Health, Inc. STRM|Syra Health Corp. (SYRA) - Debts to Book Capitalization|AMEH - Debt to Book Value Ratio|Debts to Book Capitalization MODN (Model N)|NXGN (NextGen Healthcare Inc) - Debt to Net Assets